Intrahepatic cholangiocarcinoma and hepatitis: Case study and literature review

Frank Luh, Andrew Kuei, Patricia Fann, Peiguo Chu, Yen Yen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cholangiocarcinoma is the second most common primary malignant tumor in the liver. It is a tumor that is characteristically composed of cells resembling those from the bile duct. The disease is difficult to diagnose and is usually fatal due to its late clinical presentation, lack of effective non-operative therapy, and rapid turnover. Most patients have unresectable tumors at the time of presentation and die within 12 months once diagnosis has been made. Prognosis of intrahepatic cholangiocarcinoma (ICC) remains very poor. Currently, there is no established therapy once diagnosis is made. In this report, we provide a case of a patient who presented with ICC and positive history of hepatitis C virus (HCV). The patient also had a strong family history of cancer. Finally, we attempt to review some of the important developments in the study of ICC, with particular attention to recent studies linking hepatitis with the disease.

Original languageEnglish
Pages (from-to)3239-3243
Number of pages5
JournalAnticancer Research
Volume29
Issue number8
Publication statusPublished - Aug 1 2009
Externally publishedYes

Fingerprint

Cholangiocarcinoma
Hepatitis
Neoplasms
Bile Ducts
Hepacivirus
Liver
Therapeutics

Keywords

  • Chronic disease
  • Hepatitis C
  • ICC

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Intrahepatic cholangiocarcinoma and hepatitis : Case study and literature review. / Luh, Frank; Kuei, Andrew; Fann, Patricia; Chu, Peiguo; Yen, Yen.

In: Anticancer Research, Vol. 29, No. 8, 01.08.2009, p. 3239-3243.

Research output: Contribution to journalArticle

Luh, F, Kuei, A, Fann, P, Chu, P & Yen, Y 2009, 'Intrahepatic cholangiocarcinoma and hepatitis: Case study and literature review', Anticancer Research, vol. 29, no. 8, pp. 3239-3243.
Luh, Frank ; Kuei, Andrew ; Fann, Patricia ; Chu, Peiguo ; Yen, Yen. / Intrahepatic cholangiocarcinoma and hepatitis : Case study and literature review. In: Anticancer Research. 2009 ; Vol. 29, No. 8. pp. 3239-3243.
@article{da0e7ccb067b48bfbadb0ae548dfcf14,
title = "Intrahepatic cholangiocarcinoma and hepatitis: Case study and literature review",
abstract = "Cholangiocarcinoma is the second most common primary malignant tumor in the liver. It is a tumor that is characteristically composed of cells resembling those from the bile duct. The disease is difficult to diagnose and is usually fatal due to its late clinical presentation, lack of effective non-operative therapy, and rapid turnover. Most patients have unresectable tumors at the time of presentation and die within 12 months once diagnosis has been made. Prognosis of intrahepatic cholangiocarcinoma (ICC) remains very poor. Currently, there is no established therapy once diagnosis is made. In this report, we provide a case of a patient who presented with ICC and positive history of hepatitis C virus (HCV). The patient also had a strong family history of cancer. Finally, we attempt to review some of the important developments in the study of ICC, with particular attention to recent studies linking hepatitis with the disease.",
keywords = "Chronic disease, Hepatitis C, ICC",
author = "Frank Luh and Andrew Kuei and Patricia Fann and Peiguo Chu and Yen Yen",
year = "2009",
month = "8",
day = "1",
language = "English",
volume = "29",
pages = "3239--3243",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "8",

}

TY - JOUR

T1 - Intrahepatic cholangiocarcinoma and hepatitis

T2 - Case study and literature review

AU - Luh, Frank

AU - Kuei, Andrew

AU - Fann, Patricia

AU - Chu, Peiguo

AU - Yen, Yen

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Cholangiocarcinoma is the second most common primary malignant tumor in the liver. It is a tumor that is characteristically composed of cells resembling those from the bile duct. The disease is difficult to diagnose and is usually fatal due to its late clinical presentation, lack of effective non-operative therapy, and rapid turnover. Most patients have unresectable tumors at the time of presentation and die within 12 months once diagnosis has been made. Prognosis of intrahepatic cholangiocarcinoma (ICC) remains very poor. Currently, there is no established therapy once diagnosis is made. In this report, we provide a case of a patient who presented with ICC and positive history of hepatitis C virus (HCV). The patient also had a strong family history of cancer. Finally, we attempt to review some of the important developments in the study of ICC, with particular attention to recent studies linking hepatitis with the disease.

AB - Cholangiocarcinoma is the second most common primary malignant tumor in the liver. It is a tumor that is characteristically composed of cells resembling those from the bile duct. The disease is difficult to diagnose and is usually fatal due to its late clinical presentation, lack of effective non-operative therapy, and rapid turnover. Most patients have unresectable tumors at the time of presentation and die within 12 months once diagnosis has been made. Prognosis of intrahepatic cholangiocarcinoma (ICC) remains very poor. Currently, there is no established therapy once diagnosis is made. In this report, we provide a case of a patient who presented with ICC and positive history of hepatitis C virus (HCV). The patient also had a strong family history of cancer. Finally, we attempt to review some of the important developments in the study of ICC, with particular attention to recent studies linking hepatitis with the disease.

KW - Chronic disease

KW - Hepatitis C

KW - ICC

UR - http://www.scopus.com/inward/record.url?scp=68549133268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549133268&partnerID=8YFLogxK

M3 - Article

C2 - 19661341

AN - SCOPUS:68549133268

VL - 29

SP - 3239

EP - 3243

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 8

ER -